Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$0.29
-3.0%
$0.40
$0.26
$4.85
$1.76M1.271.38 million shs83,369 shs
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$0.11
+6.0%
$0.15
$0.08
$5.65
$6.92M0.042.00 million shs1.25 million shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$2.03
+1.7%
$2.17
$1.72
$5.35
$6.52M0.6713,501 shs493 shs
WOK
WORK Medical Technology Group LTD Ordinary Shares
$0.42
-1.1%
$0.65
$0.36
$8.45
$6.19MN/A936,485 shs38,824 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
+2.37%+9.82%-26.63%-55.91%-93.66%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
+7.02%+14.57%-36.64%-47.17%-98.11%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
+1.07%+8.45%-19.11%-9.13%-53.99%
WOK
WORK Medical Technology Group LTD Ordinary Shares
-1.08%-1.67%-27.31%-91.10%+42,889,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
1.7313 of 5 stars
3.03.00.00.00.01.71.3
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
2.00
HoldN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.00
Hold$1.251,137.62% Upside
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.00
N/AN/AN/A
WOK
WORK Medical Technology Group LTD Ordinary Shares
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HSDT, STRR, LYRA, and WOK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/14/2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.00 ➝ $2.00
(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$520K3.38N/AN/A$3.32 per share0.09
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$1.53M4.34N/AN/A$1.56 per share0.06
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$53.36M0.12$0.33 per share6.11$14.63 per share0.14
WOK
WORK Medical Technology Group LTD Ordinary Shares
$11.51M0.54N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$8.85M-$5.74N/AN/A-1,764.74%-244.82%-127.10%5/12/2025 (Estimated)
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$62.68M-$1.43N/AN/AN/A-6,635.76%-125.07%-59.74%4/29/2025 (Estimated)
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$25.13M-$3.91N/AN/AN/A-12.41%-8.72%-4.62%5/19/2025 (Estimated)
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/A0.00N/AN/AN/AN/AN/A

Latest HSDT, STRR, LYRA, and WOK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q1 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.25N/AN/AN/A$16.35 millionN/A
5/12/2025Q1 2025
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$0.92N/AN/AN/A$0.10 millionN/A
4/29/2025Q1 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.15N/AN/AN/A$0.16 millionN/A
3/25/2025Q4 2024
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$0.94-$1.03-$0.09-$1.03$0.10 million$0.15 million
3/20/2025Q4 2024
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million
3/13/2025Q4 2024
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.12-$0.16-$0.04-$0.16$0.21 million$0.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/A
3.61
3.10
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
3.64
3.64
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.21
2.05
1.60
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
306.13 million3.54 millionNot Optionable
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
5065.88 million62.39 millionOptionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
4603.22 million2.14 millionNot Optionable
WOK
WORK Medical Technology Group LTD Ordinary Shares
22614.59 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Helius Medical Technologies stock logo

Helius Medical Technologies NASDAQ:HSDT

$0.29 -0.01 (-3.04%)
Closing price 03:58 PM Eastern
Extended Trading
$0.30 +0.01 (+2.79%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$0.10 +0.01 (+5.95%)
Closing price 04:00 PM Eastern
Extended Trading
$0.10 0.00 (0.00%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Star Equity stock logo

Star Equity NASDAQ:STRR

$2.02 +0.03 (+1.65%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK

$0.42 0.00 (-1.14%)
Closing price 03:50 PM Eastern
Extended Trading
$0.43 +0.01 (+1.42%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.